Functional cell-based uHTS in chemical genomic drug discovery

Trends in Biotechnology

Volumn 20, Issue 3, 2002, Pages 110-115

  Croston, Glenn E ^a  

^a ACADIA PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; DRUG THERAPY; GENES; SCREENING;

LIGAND-BINDING ASSAYS;

BIOTECHNOLOGY;

CELL NUCLEUS RECEPTOR; CYTOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GREEN FLUORESCENT PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MUSCARINIC AGENT; PROTEINASE; SEROTONIN ANTAGONIST; STEROL REGULATORY ELEMENT BINDING PROTEIN;

DRUG DEVELOPMENT;

BINDING ASSAY; BINDING COMPETITION; BIOSENSOR; CHEMICAL GENETICS; DRUG BINDING SITE; GENE FUNCTION; GENE SEQUENCE; GENE TARGETING; IMMUNOASSAY; LIGAND BINDING; MELANOPHORE; PRIORITY JOURNAL; REVIEW; VALIDATION PROCESS;

MELANOPHORA;

EID: 0036498752     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(02)01906-6     Document Type: Review

References (38)

1. Drug discovery: A historical perspective
2. Initial sequencing and analysis of the human genome
3. The sequence of the human genome
4. HTS in the new millennium: The role of pharmacology and flexibility
5. High-throughput and ultra-high-throughput screening: Solution- and cell-based approaches
6. New assay technologies for high-throughput screening
7. Intracellular detection assays for high-throughput screening
8. Too many targets, not enough target validation
9. Transgenic gene knock-outs: Functional genomics and therapeutic target selection
10. The impact of genomics on drug discovery
11. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product
12. Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry
13. CPCCOEt, a non-competitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding
14. Novel software tools for chemical diversity
15. 5HT2a receptor inverse agonists as antipsychotics
16. Orphan G-protein-coupled receptors and natural ligand discovery
17. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
18. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
19. Cell-based versus isolated target screening: How lucky do you feel?
20. Molecular medicine. The cholesterol quartet
21. Drug discovery and the intracellular receptor family
22. High throughput assays of cloned adrenergic, muscarinic, neurokinin, and neurotrophin receptors in living mammalian cells
23. Tools for investigating functional interactions between ligands and G-protein-coupled receptors
24. Amphibian melanophore technology as a functional screen for antagonists of G-protein coupled 7-transmembrane receptors
25. Use of a cell-based, lawn format assay to rapidly screen a 442,368 bead-based peptide library
26. 2+] using the Fluorometric Imaging Plate Reader (FLIPR)
27. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells
28. A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor
29. Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter
30. High throughput quantitation of cAMP production mediated by activation of seven transmembrane domain receptors
31. Development of a functional reporter gene HTS assay for the identification of mGluR7 modulators
32. A novel high throughput chemiluminescent assay for the measurement of cellular cyclic adenosine monophosphate levels
33. 2+ based on green fluorescent proteins and calmodulin
34. A genetically encoded, fluorescent indicator for cyclic AMP in living cells
35. Cell-based assays and instrumentation for screening ion-channel targets
36. A comparative cell-based high throughput screening strategy for the discovery of selective tyrosine kinase inhibitors with anticancer activity
37. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
38. Paclitaxel (Taxol): A success story with valuable lessons for natural product drug discovery and development